Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Xichao Dai"'
Publikováno v:
Cancer Medicine, Vol 12, Iss 15, Pp 16108-16118 (2023)
Abstract Background: Esophageal squamous cell cancer (ESCC) accounts for approximately 90% of esophageal cancer cases in China. There are no standard regimens for second or third–line chemotherapy of metastatic squamous esophageal cancer. The objec
Externí odkaz:
https://doaj.org/article/1f20bece7a104b319723a4211f525e90
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundPreclinical trials of immunotherapy in ovarian cancer (OC) have shown promising results. This makes it meaningful to prospectively examine the biological mechanisms explaining the differences in response performances to immunotherapy among
Externí odkaz:
https://doaj.org/article/8a60ed8f649b4af8aa04b92190a74427
Autor:
Xiaodong Li, Xichao Dai, Liangrong Shi, Yong Jiang, Xuemin Chen, Lujun Chen, Jiemin Zhao, Weiguang Qiang, Jun Wu, Mei Ji, Jingting Jiang, Changping Wu
Publikováno v:
Cellular Physiology and Biochemistry, Vol 40, Iss 1-2, Pp 137-145 (2016)
Purpose: This phase II/III, non-randomized clinical trial aimed to determine the efficacy and safety of the combination of radiofrequency ablation (RFA) and cytokine-induced killer (CIK) cells transfusion for patients with colorectal liver metastases
Externí odkaz:
https://doaj.org/article/1b645bc1e0214f338385f07af9e2700e
Publikováno v:
Historical Biology. :1-7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::254708449c022483b4d64cc7c38a2a0b
https://doi.org/10.1080/08912963.2022.2130793
https://doi.org/10.1080/08912963.2022.2130793
Publikováno v:
Historical Biology. :1-12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c7b9fbb4349ff4c3a25ba34a1da29bb
https://doi.org/10.1080/08912963.2022.2077647
https://doi.org/10.1080/08912963.2022.2077647
Autor:
Jingting Jiang, Binfeng Lu, Quansheng Lv, Min Yang, Xichao Dai, Wen Wen, Mingfen Sun, Xiao Zheng, Bin Xu, Yibei Zhu, Changping Wu, Lujun Chen, Liangrong Shi
Purpose: Radiofrequency ablation (RFA) has been shown to elicit tumor-specific T-cell immune responses, but is not sufficient to prevent cancer progression. Here, we investigated immune-suppressive mechanisms limiting the efficacy of RFA.Experimental
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5463f34700f23e761bf67a3b6e00e942
https://doi.org/10.1158/1078-0432.c.6523718
https://doi.org/10.1158/1078-0432.c.6523718
Autor:
Jingting Jiang, Binfeng Lu, Quansheng Lv, Min Yang, Xichao Dai, Wen Wen, Mingfen Sun, Xiao Zheng, Bin Xu, Yibei Zhu, Changping Wu, Lujun Chen, Liangrong Shi
Supplemental figure 1. Patient cohort and study design. Supplemental Figure 2. Immunochemical staining of PD-L1 antibody (1:500, clone: SP142) on the paraffin-embedded human melanoma and placenta tissues. Supplemental Figure 3. RFA of colorectal live
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51f7d8ad642f9161eefed172a9f613f0
https://doi.org/10.1158/1078-0432.22457843.v1
https://doi.org/10.1158/1078-0432.22457843.v1
Autor:
Xichao Dai, Yumei Ding
Publikováno v:
Contrast Media & Molecular Imaging
Contrast Media & Molecular Imaging, Vol 2021 (2021)
Contrast Media & Molecular Imaging, Vol 2021 (2021)
In order to improve the accuracy of the evaluation results of multiperception intelligent wearable devices, the mathematical statistical characteristics based on speech, behavior, environment, and physical signs are proposed; first, the PCA feature c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1885f45da21207dfc532443efc6c28d8
https://doi.org/10.1155/2021/8307576
https://doi.org/10.1155/2021/8307576
Background and Purpose:To immune checkpoint inhibitors (immune checkpoint inhibitors, ICIs) as the representative of immunotherapy is more and more widely used in the treatment of lung cancer, this study was to evaluate the recurrent metastatic non-s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::611e656452841b8bc74d2880c5756d4c
https://doi.org/10.21203/rs.3.rs-2068385/v1
https://doi.org/10.21203/rs.3.rs-2068385/v1
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2020 (2020)
BioMed Research International, Vol 2020 (2020)
Purposes. Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world. Recent researches have demonstrated that m6A methylation regulators play a key role in various cancers, such as gastric cancer and colon adenocarcinoma.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c0129bee150fee7434b01c03359eb5a
https://pubmed.ncbi.nlm.nih.gov/32733931
https://pubmed.ncbi.nlm.nih.gov/32733931